Hypergastrinemia promotes adenoma progression in the APCMin-/+ mouse model of familial adenomatous polyposis

Cancer Research

Volumn 61, Issue 2, 2001, Pages 625-631

  Watson, S A ^a   Smith, A M ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; GASTRIN; OMEPRAZOLE; PARIETAL CELL ANTIBODY;

ADENOMATOUS POLYP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL DISEASE; GASTRIN BLOOD LEVEL; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BROMODEOXYURIDINE; CANCER VACCINES; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DIPHTHERIA TOXOID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GASTRINS; GENE EXPRESSION REGULATION; HETEROZYGOTE; IMMUNIZATION; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OMEPRAZOLE; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RNA, MESSENGER; SURVIVAL RATE;

EID: 0035863511     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin
2. Antiproliferative effects of gastrin receptor aotagonists and antibodies to gastrin on human colon carcinoma cell lines
3. A Role of autocrine and endocrine gastrin-like peptides in colonic carcinogenesis
4. Relative abundance of big and little gastrins in the tumors and blood of patients with the Zollinger Ellison syndrome
5. Pathomorphologic, biochemical and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome)
6. Gastrinoma
7. Identification of gastrin molecular variants in gastrinoma syndrome
8. Serum gastrin concentrations in pernicious anemia
9. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori
10. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects
11. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment
12. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels
13. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia
14. Pernicious anaemia as a risk factor in gastric cancer
15. Cancer risk following pernicious anaemia
16. Prolonged hypergastrinaemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellinson syndrome
17. Gastrin and colorectal cancer: A prospective study
18. Gastrin and gastrin receptor activation - An early event in the adenoma-carcinoma sequence
19. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity
20. A dominant mutation thai predisposes of multiple intestinal neoplasia in the mouse
21. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer
22. Identification of progastrin derived peptides in colorectal carcinoma extracts
23. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis
24. Effect of food on the bioavailability of omeprazole
25. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion
26. Differential responsiveness of proximal and distal colonic mucosa to gastrin
27. Titrated thymidine labeling distribution as a marker for hereditary predisposition to colon cancer
28. Rectal cell proliferation and colon cancer risk in ulcerative colitis
29. Effect of gastrin neutralization on the progression of the adenoma: Carcinoma sequence in the Min mouse model of familial adenomatous polyposis
30. The role of gastrin in the adenoma:carcinoma sequence in the colon
31. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen
32. Gastrin - A potential therapeutic target in oesophageal adenocarcinoma and Barrett's oesophagus
33. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM